The Cutaneous Melatoninergic System: Endogenous Biology and Potential for Therapeutic Targeting
Experimental Dermatology · 2026-11 · 35 (11)
DOI: 10.1111/exd.70380 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Dermatology, online erschienen am 31.10.2026. Verfasst von Ju Hee Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, Korea. Hauptthemen laut MEDLINE: Melatonin, Skin. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Health & Welfare, Korea, Translational R&D through the Institute for Bio-Medical Convergence, Incheon St. Mary's Hospital, The Catholic University of Korea.
Abstract (Originalsprache)
Melatonin is best known as a pineal hormone that regulates circadian rhythms, but the skin also possesses an intrinsic melatoninergic system capable of local synthesis, metabolism and signalling. This system encompasses classical melatonin receptors, biologically active metabolites, non‐classical signalling pathways and receptor‐independent intracellular actions involved in cutaneous stress responses, with emerging evidence for broader roles in skin homeostasis. In this review, we integrate current mechanistic and clinical evidence on the cutaneous melatoninergic system and critically examine its therapeutic relevance. Human evidence is most consistent for the photoprotective effects of topical melatonin, whereas clinical data for photoaging, radiation dermatitis, wound healing, hair disorders, inflammatory dermatoses, pigmentary disorders and chronic pruritus remain limited or preliminary. Interpretation is further constrained by small sample sizes, heterogeneous formulations, short follow‐up and frequent use of combination products. Importantly, the clinical efficacy of exogenous melatonin and evidence that the endogenous cutaneous melatoninergic system represents a disease‐modifying therapeutic target are distinct questions. Establishing the therapeutic relevance of the endogenous system will require characterisation of disease‐associated alterations in local melatonin synthesis, metabolism and signalling, demonstration of molecular target engagement, and linkage to clinically meaningful outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, Korea.
- Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, Korea.
ORCID-Profile: Ju Hee Han, Hei Sung Kim
Förderung
- National Research Foundation of Korea
- Ministry of Health & Welfare, Korea
- Translational R&D through the Institute for Bio-Medical Convergence, Incheon St. Mary's Hospital, The Catholic University of Korea
Zitieren
APA
Han, J. H., & Kim, H. S. (2026). The Cutaneous Melatoninergic System: Endogenous Biology and Potential for Therapeutic Targeting. Experimental Dermatology, 35(11). https://doi.org/10.1111/exd.70380
Vancouver
Han JH, Kim HS. The Cutaneous Melatoninergic System: Endogenous Biology and Potential for Therapeutic Targeting. Experimental Dermatology. 2026;35(11). doi:10.1111/exd.70380
BibTeX
@article{Han2026,
author = {Han, Ju Hee and Kim, Hei Sung},
title = {The Cutaneous Melatoninergic System: Endogenous Biology and Potential for Therapeutic Targeting},
journal = {Experimental Dermatology},
year = {2026},
volume = {35},
number = {11},
doi = {10.1111/exd.70380}
}
EUVIMED